Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 154 results found. Search for [ HIV ]

Results 20 to 40 of 154
Mail Today Bureau
New Delhi, June 28, 2017
Ahead of the GST rollout on July 1, the National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices of 761 medicines which includes a list of antibiotics and drugs for treating cancer, HIV, diabetes.


Joe C Mathew
New Delhi, June 23, 2017
Medicines Sans Frontiers (MSF) has urged India to withstand U.S. pressure to change its drug regulatory and patent system as it could result in millions of people in the U.S. and around the world losing their lifeline of affordable medicines.


Reuters
New Delhi, June 7, 2017
India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients.


BT Online
June 5, 2017
India's biggest tax overhaul crossed its final hurdle last week when GST Council agreed to tax gold and silver jewellery at 3 per cent tax rate.


Joe C Mathew
New Delhi, May 17, 2017
With presence in over 100 countries, India being one of its key geographies, the foundation aims to help find solutions to reduce extreme poverty and improve health.


Reuters
New Delhi/Mumbai, April 30, 2017
A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter.


BT Online
New Delhi, April 5, 2017
BSE Sensex ended the day 29,974.24, up 64.02 points after touching and intra day high of 30,007, while the NSE Nifty held above its 9,250-mark closing the day at 9,265.15, up 27.30 points.


Associated Press
New Delhi, March 22, 2017
Apple is cutting prices on two iPad models, but the company held back on updating its higher-end iPad Pro tablets.


By Joe C. Mathew
Delhi, March 20, 2017
In spite of favourable court verdicts, top pharmaceutical companies are losing enthusiasm for fixed dose combination medicines.


E Kumar Sharma
February 24, 2017
What should then be made of statements from Cipla about its foray in Brazil and China? Is it only following others into these markets?


Reuters
January 31, 2017
India's health ministry is likely to see a substantial increase in funding, after it warned that its programmes were short of cash and sought more than $1.2 billion in additional money, according to government officials and documents.


Reuters
December 1, 2016
Delhi High Court on Thursday stayed a government ban on 344 drugs that it deemed lacked therapeutic efficacy, after over six months of hearing more than 300 petitions filed by drug-makers against it.


By Avneet Kaur
Delhi, October 2, 2016
We bring you tips for making a financial plan so that you can lead a stress-free life.


PTI
Mumbai, September 22, 2016
Market benchmark Sensex rebounded by 266 points today to close at over two-week high of 28,773.13 and the NSE Nifty went past the 8,800-mark, tracking upbeat global cues after the US Federal Reserve left rates unchanged.


PTI
New Delhi, August 19, 2016
\"NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013,\" the National Pharmaceutical Pricing Authority (NPPA) said in a statement.


PTI
New York, August 19, 2016
The second annual 'Change the World' list is topped by UK's GlaxoSmithkline, followed by Israel-based IDE Technologies and American conglomerate General Electric at the second and third positions, respectively.


Joe C Mathew
August 3, 2016
US-based portable molecular diagnostic products firm Alere Inc has set up its first integrated manufacturing facility in Manesar, near Delhi.


PTI
New Delhi, August 1, 2016
\"National Pharmaceutical Pricing Authority (NPPA) has fixed/revised ceiling prices of 24 scheduled formulations of schedule-I under Drugs (Price Control) Amendment Order, 2016,\" the drug pricing regulator said in a order on its website.


by Sarabjeet kaur
Delhi, July 23, 2016
All that you need to know before filing a claim during overseas travel.


By E. Kumar Sharma
Delhi, July 23, 2016
Indian drug makers are slugging it out with Big Pharma over launch of biosimilars. Will they be able to hold their fort in this emerging space?


PAGES 2 OF 8  12345